Epilepsy is a condition affecting around 65 million people worldwide, of which 70% of its cases respond well to treatment and 30% are drug-resistant. Treatment to date has focused on blocking brain signals, but an international multi-year study in this direction has identified molecules with which a new perspective of treatment options for epilepsy is opening up.